• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Intravascular ATP and coronary vasodilation in the isolated working rat heart.离体工作大鼠心脏中的血管内ATP与冠状动脉舒张
Br J Pharmacol. 1999 Jun;127(3):701-8. doi: 10.1038/sj.bjp.0702610.
2
Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors.尿苷腺苷四磷酸是冠状动脉微循环中的一种新型血管扩张剂,通过嘌呤能 P1 受体而非 P2 受体发挥作用。
Pharmacol Res. 2013 Jan;67(1):10-7. doi: 10.1016/j.phrs.2012.09.011. Epub 2012 Oct 9.
3
A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release.一种新的血管调节机制:ADP诱导的猪离体冠状动脉舒张是通过腺苷释放介导的。
FASEB J. 2007 Feb;21(2):577-85. doi: 10.1096/fj.06-7050com. Epub 2006 Dec 13.
4
Responses of the longitudinal muscle and the muscularis mucosae of the rat duodenum to adenine and uracil nucleotides.大鼠十二指肠纵行肌和黏膜肌层对腺嘌呤和尿嘧啶核苷酸的反应。
Br J Pharmacol. 1996 Mar;117(5):823-30. doi: 10.1111/j.1476-5381.1996.tb15267.x.
5
Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.在大鼠脑内小动脉中产生舒张作用的P2受体亚型的比较。
Stroke. 2003 Jun;34(6):1473-8. doi: 10.1161/01.STR.0000071527.10129.65. Epub 2003 May 1.
6
Contractile effects of uridine 5'-triphosphate in the rat duodenum.尿苷 5'-三磷酸对大鼠十二指肠的收缩作用。
Br J Pharmacol. 1994 Dec;113(4):1191-6. doi: 10.1111/j.1476-5381.1994.tb17123.x.
7
Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries.大鼠离体小肠系膜动脉中ATP和UTP从扩张到管腔灌注的扩散
J Physiol. 2007 Jul 1;582(Pt 1):335-47. doi: 10.1113/jphysiol.2007.135202. Epub 2007 May 3.
8
Nucleotide coronary vasodilation in guinea pig hearts.豚鼠心脏中的核苷酸冠状动脉舒张
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1040-7. doi: 10.1152/ajpheart.00981.2002. Epub 2003 May 22.
9
Purinoceptors in the rat heart.大鼠心脏中的嘌呤受体。
Br J Pharmacol. 1987 Jan;90(1):219-27. doi: 10.1111/j.1476-5381.1987.tb16843.x.
10
UTP induces vascular responses in the isolated and perfused canine epicardial coronary artery via UTP-preferring P2Y receptors.尿苷三磷酸(UTP)通过尿苷三磷酸偏好性P2Y受体在离体灌注的犬心外膜冠状动脉中诱导血管反应。
Br J Pharmacol. 1997 Dec;122(8):1625-32. doi: 10.1038/sj.bjp.0701559.

引用本文的文献

1
NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow.NTPDase1/CD39 核苷酸酶对正常动脉直径适应血流至关重要。
Int J Mol Sci. 2023 Oct 10;24(20):15038. doi: 10.3390/ijms242015038.
2
Monitoring of mitochondrial oxygen tension in the operating theatre: An observational study with the novel COMET® monitor.手术室内线粒体氧张力监测:新型 COMET® 监测器的观察性研究。
PLoS One. 2023 Feb 9;18(2):e0278561. doi: 10.1371/journal.pone.0278561. eCollection 2023.
3
Cardiac purinergic signalling in health and disease.健康与疾病中的心脏嘌呤能信号传导
Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20.
4
Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries.猪离体胰腺动脉中嘌呤和嘧啶受体功能表达的研究。
Purinergic Signal. 2014;10(2):241-9. doi: 10.1007/s11302-013-9403-2. Epub 2013 Dec 6.
5
Loss of ectonucleotidases from the coronary vascular bed after ischemia-reperfusion in isolated rat heart.缺血再灌注后分离大鼠心脏冠状血管床中外核苷酸酶的丢失。
BMC Cardiovasc Disord. 2013 Jul 28;13:53. doi: 10.1186/1471-2261-13-53.
6
Functional contribution of P2Y1 receptors to the control of coronary blood flow.P2Y1 受体在冠状动脉血流控制中的功能贡献。
J Appl Physiol (1985). 2011 Dec;111(6):1744-50. doi: 10.1152/japplphysiol.00946.2011. Epub 2011 Sep 22.
7
P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2.P2Y1受体信号传导受与PDZ支架蛋白NHERF-2相互作用的调控。
Proc Natl Acad Sci U S A. 2005 May 31;102(22):8042-7. doi: 10.1073/pnas.0408818102. Epub 2005 May 18.
8
Nucleotide coronary vasodilation in guinea pig hearts.豚鼠心脏中的核苷酸冠状动脉舒张
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1040-7. doi: 10.1152/ajpheart.00981.2002. Epub 2003 May 22.

本文引用的文献

1
Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow.缺氧时的心脏核苷酸:在冠状动脉血流调节中的可能作用。
Am J Physiol. 1963 Feb;204:317-22. doi: 10.1152/ajplegacy.1963.204.2.317.
2
Evaluation of a lumped parameter model for isolated working rat hearts.对离体工作大鼠心脏集总参数模型的评估。
Med Biol Eng Comput. 1999 Mar;37(2):190-5. doi: 10.1007/BF02513286.
3
Agonist-induced internalization of the P2Y2 receptor.激动剂诱导的P2Y2受体内化
Mol Pharmacol. 1998 Sep;54(3):485-94. doi: 10.1124/mol.54.3.485.
4
Action of Al-ATP on the isolated working rat heart.铝-三磷酸腺苷对离体大鼠工作心脏的作用。
J Inorg Biochem. 1998 Feb 15;69(3):153-8. doi: 10.1016/s0162-0134(97)10012-5.
5
Pharmacological analysis of responses to ATP in the isolated and perfused canine coronary artery.离体灌注犬冠状动脉对ATP反应的药理学分析
Eur J Pharmacol. 1997 Sep 10;334(2-3):173-80. doi: 10.1016/s0014-2999(97)01167-9.
6
The past, present and future of purine nucleotides as signalling molecules.嘌呤核苷酸作为信号分子的过去、现在与未来
Neuropharmacology. 1997 Sep;36(9):1127-39. doi: 10.1016/s0028-3908(97)00125-1.
7
Towards a revised nomenclature for P1 and P2 receptors.迈向P1和P2受体的修订命名法。
Trends Pharmacol Sci. 1997 Mar;18(3):79-82. doi: 10.1016/s0165-6147(96)01038-3.
8
Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.克隆的P2Y受体的药理学和第二信使信号选择性
J Auton Pharmacol. 1996 Dec;16(6):319-23. doi: 10.1111/j.1474-8673.1996.tb00044.x.
9
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.P2Y1受体是一种由三磷酸腺苷(ATP)拮抗的二磷酸腺苷(ADP)受体,在血小板和巨核母细胞中表达。
FEBS Lett. 1997 Feb 10;403(1):26-30. doi: 10.1016/s0014-5793(97)00022-7.
10
Cloning of the rat P2u receptor and its potential role in coronary vasodilation.大鼠P2u受体的克隆及其在冠状动脉舒张中的潜在作用。
Am J Physiol. 1996 Feb;270(2 Pt 1):C570-7. doi: 10.1152/ajpcell.1996.270.2.C570.

离体工作大鼠心脏中的血管内ATP与冠状动脉舒张

Intravascular ATP and coronary vasodilation in the isolated working rat heart.

作者信息

Korchazhkina O, Wright G, Exley C

机构信息

Birchall Centre for Inorganic Chemistry and Materials Science, Department of Chemistry, Keele University, Staffordshire.

出版信息

Br J Pharmacol. 1999 Jun;127(3):701-8. doi: 10.1038/sj.bjp.0702610.

DOI:10.1038/sj.bjp.0702610
PMID:10401561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1566071/
Abstract
  1. Adenosine-5'-triphosphate (ATP) is a potent coronary vasodilator. Because of the efficient hydrolysis of ATP, adenosine-5'-diphosphate (ADP) and adenosine-5'-monophosphate (AMP) by ectonucleotidases located in the coronary endothelium ATP-induced vasodilation may be mediated via both P1 (AMP and adenosine) and P2Y (ATP and ADP) receptors. We have used the change in total coronary resistance (TCR) induced by intravascular ATP in the isolated working rat heart to determine both the component of the vasodilation mediated via P2Y receptors and the identity of the subclass of receptor involved. 2. The dose response for ATP revealed a half maximal effect at an apparent ATP concentration of 0.08 +/- 0.009 microM. The response was saturated at apparent ATP concentrations greater than 0.23 microM. Contrary to much of the current literature, the perfusion of a 0.25 microM concentration of adenosine resulted in the identical response to an equimolar concentration of ATP suggesting a significant role for adenosine in coronary vasodilation. 3. The non-selective P1 receptor antagonist 8-(p-Sulfophenyl)theophylline (8-SPT) was used to show that the response to ATP was mediated via both P1 and P2Y receptors. Whilst 8-SPT abolished the effect of adenosine it reduced the effect of ATP by only 50%. Thus, at a saturating concentration of ATP, P1 and P2Y receptors were shown to contribute equally to the observed vasodilation. 4. Uridine-5'-triphosphate (UTP), ADP and adenosine-5'-O-thiotriphosphate (ATP gamma S) were used to characterize the component of coronary vasodilation that was mediated via P2Y receptors. UTP at 0.25 microM was ineffective and did not induce vasodilation. Perfusion with 0.25 microM ADP resulted in a vasodilation that was identical to 0.25 microM ATP. In the absence of 8-SPT the perfusion of 0.25 microM ATP gamma S produced a vasodilation that was significantly (P < 0.05) less than ATP. However, the vasodilation due to ATP gamma S, like that of adenosine, but unlike that of both ATP and ADP, was abolished in the presence of 8-SPT. The ability of ADP to induce vasodilation combined with both the lack of response to UTP and the ability of 8-SPT to abolish the vasodilation induced by ATP gamma S suggested very strongly that the component of ATP-induced coronary vasodilation in the isolated working rat heart that was mediated via P2Y receptors was achieved by the action of ADP (and not ATP) at P2Y1 receptors. 5. These results suggest that the vasodilatory action of intravascular ATP in the coronary circulation should be attributed to the dual and equal activities of adenosine and ADP acting at P1 and P2Y1 receptors respectively.
摘要
  1. 腺苷 - 5'-三磷酸(ATP)是一种强效的冠状动脉血管扩张剂。由于位于冠状动脉内皮的外核苷酸酶能高效水解ATP,生成腺苷 - 5'-二磷酸(ADP)和腺苷 - 5'-单磷酸(AMP),ATP诱导的血管舒张可能通过P1(AMP和腺苷)和P2Y(ATP和ADP)受体介导。我们利用离体工作大鼠心脏中血管内ATP诱导的总冠状动脉阻力(TCR)变化,来确定通过P2Y受体介导的血管舒张成分以及所涉及的受体亚类。2. ATP的剂量反应在表观ATP浓度为0.08±0.009微摩尔时显示出半数最大效应。在表观ATP浓度大于0.23微摩尔时反应达到饱和。与当前许多文献相反,灌注0.25微摩尔浓度的腺苷导致的反应与等摩尔浓度的ATP相同,这表明腺苷在冠状动脉血管舒张中起重要作用。3. 非选择性P1受体拮抗剂8 - (对 - 磺基苯基)茶碱(8 - SPT)用于表明对ATP的反应是通过P1和P2Y受体介导的。虽然8 - SPT消除了腺苷的作用,但它仅使ATP的作用降低了50%。因此,在ATP饱和浓度下,P1和P2Y受体对观察到的血管舒张作用相同。4. 尿苷 - 5'-三磷酸(UTP)、ADP和腺苷 - 5'-O - 硫代三磷酸(ATPγS)用于表征通过P2Y受体介导的冠状动脉血管舒张成分。0.25微摩尔的UTP无效,未诱导血管舒张。灌注0.25微摩尔的ADP导致的血管舒张与0.25微摩尔的ATP相同。在没有8 - SPT的情况下,灌注0.25微摩尔的ATPγS产生的血管舒张明显(P < 0.05)小于ATP。然而,与腺苷一样,但与ATP和ADP不同,ATPγS引起的血管舒张在存在8 - SPT时被消除。ADP诱导血管舒张的能力,以及对UTP缺乏反应和8 - SPT消除ATPγS诱导的血管舒张的能力,非常强烈地表明,在离体工作大鼠心脏中,通过P2Y受体介导的ATP诱导的冠状动脉血管舒张成分是由ADP(而非ATP)作用于P2Y1受体实现的。5. 这些结果表明,冠状动脉循环中血管内ATP的血管舒张作用应归因于腺苷和ADP分别作用于P1和P2Y1受体的双重且相同的活性。